﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2019v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2021-05-17T05:56:58-00:00</ReturnTs>
    <TaxPeriodEndDt>2020-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>LEWIS SHARPSTONE &amp; CO</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>5850 CANOGA AVE SUITE 400</AddressLine1Txt>
        <CityNm>WOODLAND HILLS</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91367</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2019-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>561683450</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>SOLVE ME CFS INITIATIVE INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>SOLV</BusinessNameControlTxt>
      <PhoneNum>7043640016</PhoneNum>
      <USAddress>
        <AddressLine1Txt>350 N GLENDALE BLVD SUITE B Room 36</AddressLine1Txt>
        <CityNm>Glendale</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91206</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>OVED AMITAY</PersonNm>
      <PersonTitleTxt>PRESIDENT AND CEO</PersonTitleTxt>
      <SignatureDt>2021-05-17</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>LEWIS SHARPSTONE</PreparerPersonNm>
      <PhoneNum>8185701960</PhoneNum>
      <PreparationDt>2021-05-17</PreparationDt>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2019</TaxYr>
    <BuildTS>2022-09-23 18:48:47Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="990" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <PrincipalOfficerNm>OVED AMITAY</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>350 N GLENDALE BLVD STE B 368</AddressLine1Txt>
        <CityNm>GLENDALE</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91206</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>3674180</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.SOLVECFS.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1987</FormationYr>
      <LegalDomicileStateCd>CA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE SOLVE ME/CFS INITIATIVE SMCI IS A LEADING ORGANIZATION FOCUSED ON ME/CFS.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>14</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>13</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>13</TotalEmployeeCnt>
      <TotalVolunteersCnt>13</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>2594708</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>3667511</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>786</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>2037</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>800</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2596294</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>3669548</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>223500</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>354217</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>948058</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1239302</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>9410</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>11120</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>200002</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>740521</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1183667</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>1921489</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2788306</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>674805</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>881242</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>1434405</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>2460484</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>85330</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>295849</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>1349075</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>2164635</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE SOLVE ME/CFS INITIATIVE SMCIIS THE LEADING ORGANIZATION FOCUSED ON MYALGIC ENCEPHALOMYELITIS ME/CHRONIC FATIGUE SYNDROME CFS, SINCE BEING FOUNDED IN 1987. SMCI ENVISIONS A WORLD FREE OF ME/CFS AND WORKS STEADFASTLY TO MAKE THIS DISEASE UNDERSTOOD, DIAGNOSABLE, AND TREATABLE.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>1255863</ExpenseAmt>
      <GrantAmt>354217</GrantAmt>
      <Desc>RESEARCH ACCOMPLISHMENTS - SEE SCHEDULE O</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>860593</ExpenseAmt>
        <Desc>ADVOCACY AND ENGAGEMENT ACCOMPLISHMENTS - SEE SCHEDULE O</Desc>
      </ProgSrvcAccomActy2Grp>
      <TotalProgramServiceExpensesAmt>2116456</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="990A">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="990B">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="990C">true</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="990D">true</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="990D">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="990D">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="990D">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="990D">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd>false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="990F">true</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="990F">true</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="990I">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <InvestTaxExemptBondsInd>false</InvestTaxExemptBondsInd>
      <EscrowAccountInd>false</EscrowAccountInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="990M">true</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <InfoInScheduleOPartVInd>X</InfoInScheduleOPartVInd>
      <IRPDocumentCnt>4</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>13</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>14</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>13</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>SC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <BooksInCareOfDetail>
        <PersonNm>DEBORAH SAADY</PersonNm>
        <PhoneNum>7043640016</PhoneNum>
        <USAddress>
          <AddressLine1Txt>350 N GLENDALE BLVD STE B 368</AddressLine1Txt>
          <CityNm>GLENDALE</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91206</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARYELLEN GLEASON TO MAY 2020</PersonNm>
        <TitleTxt>INTERIM PRESIDENT AND CEO</TitleTxt>
        <AverageHoursPerWeekRt>040.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>136538</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>10693</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SADIE WHITTAKER</PersonNm>
        <TitleTxt>CHIEF SCIENTIFIC OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>040.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>137500</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>EMILY TAYLOR</PersonNm>
        <TitleTxt>DIRECTOR OF ADVOCACY AND COMMUNITY RELATIONS</TitleTxt>
        <AverageHoursPerWeekRt>040.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>101154</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>OVED AMITAY FROM JUNE 2020</PersonNm>
        <TitleTxt>PRESIDENT AND CEO</TitleTxt>
        <AverageHoursPerWeekRt>040.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MIKE ATHERTON</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>003.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANDREA BANKOSKI</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VICTORIA BOIES</PersonNm>
        <TitleTxt>VICE-CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>003.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WILLIAM HASSLER</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CAROL HEAD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RONA KRAMER</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARBARA LUBASH</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>003.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN NICOLS</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>005.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>AMRIT SHAHZAD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICK SPROUT</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JEFFREY TOBIAS FROM JANUARY 2020</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KARL ZEILE FROM AUGUST 2019</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JANICE STANTON</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>002.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>375192</TotalReportableCompFromOrgAmt>
      <TotalOtherCompensationAmt>10693</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>3</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <GovernmentGrantsAmt>304758</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>3362753</AllOtherContributionsAmt>
      <NoncashContributionsAmt>45144</NoncashContributionsAmt>
      <TotalContributionsAmt>3667511</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>2037</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2037</RelatedOrExemptFuncIncomeAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>4632</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>4632</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>3669548</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2037</RelatedOrExemptFuncIncomeAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>314217</TotalAmt>
        <ProgramServicesAmt>314217</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>40000</TotalAmt>
        <ProgramServicesAmt>40000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>273261</TotalAmt>
        <ProgramServicesAmt>81979</ProgramServicesAmt>
        <ManagementAndGeneralAmt>109306</ManagementAndGeneralAmt>
        <FundraisingAmt>81976</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>0</TotalAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>751074</TotalAmt>
        <ProgramServicesAmt>648334</ProgramServicesAmt>
        <ManagementAndGeneralAmt>93094</ManagementAndGeneralAmt>
        <FundraisingAmt>9646</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>18799</TotalAmt>
        <ProgramServicesAmt>6453</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11728</ManagementAndGeneralAmt>
        <FundraisingAmt>618</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>112734</TotalAmt>
        <ProgramServicesAmt>59667</ProgramServicesAmt>
        <ManagementAndGeneralAmt>40157</ManagementAndGeneralAmt>
        <FundraisingAmt>12910</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>83434</TotalAmt>
        <ProgramServicesAmt>40000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>29539</ManagementAndGeneralAmt>
        <FundraisingAmt>13895</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>15501</TotalAmt>
        <ProgramServicesAmt>7363</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5720</ManagementAndGeneralAmt>
        <FundraisingAmt>2418</FundraisingAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>80953</TotalAmt>
        <ProgramServicesAmt>80953</ProgramServicesAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>11120</TotalAmt>
        <FundraisingAmt>11120</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>0</TotalAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>195166</TotalAmt>
        <ProgramServicesAmt>133611</ProgramServicesAmt>
        <ManagementAndGeneralAmt>49081</ManagementAndGeneralAmt>
        <FundraisingAmt>12474</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>0</TotalAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>78752</TotalAmt>
        <ProgramServicesAmt>37762</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28749</ManagementAndGeneralAmt>
        <FundraisingAmt>12241</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>140959</TotalAmt>
        <ProgramServicesAmt>89401</ProgramServicesAmt>
        <ManagementAndGeneralAmt>38426</ManagementAndGeneralAmt>
        <FundraisingAmt>13132</FundraisingAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>71034</TotalAmt>
        <ProgramServicesAmt>33741</ProgramServicesAmt>
        <ManagementAndGeneralAmt>26212</ManagementAndGeneralAmt>
        <FundraisingAmt>11081</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>69149</TotalAmt>
        <ProgramServicesAmt>54043</ProgramServicesAmt>
        <ManagementAndGeneralAmt>10616</ManagementAndGeneralAmt>
        <FundraisingAmt>4490</FundraisingAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>0</TotalAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>0</TotalAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>626</TotalAmt>
        <ProgramServicesAmt>298</ProgramServicesAmt>
        <ManagementAndGeneralAmt>231</ManagementAndGeneralAmt>
        <FundraisingAmt>97</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>9581</TotalAmt>
        <ProgramServicesAmt>4550</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3536</ManagementAndGeneralAmt>
        <FundraisingAmt>1495</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>RESEARCH</Desc>
        <TotalAmt>326410</TotalAmt>
        <ProgramServicesAmt>326410</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PRINTING AND POSTAGE</Desc>
        <TotalAmt>131645</TotalAmt>
        <ProgramServicesAmt>95058</ProgramServicesAmt>
        <ManagementAndGeneralAmt>24178</ManagementAndGeneralAmt>
        <FundraisingAmt>12409</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>ADVOCACY AND COMMUNICATION</Desc>
        <TotalAmt>63891</TotalAmt>
        <ProgramServicesAmt>62616</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1275</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>0</TotalAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2788306</TotalAmt>
        <ProgramServicesAmt>2116456</ProgramServicesAmt>
        <ManagementAndGeneralAmt>471848</ManagementAndGeneralAmt>
        <FundraisingAmt>200002</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>1054016</BOYAmt>
        <EOYAmt>618851</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>187767</BOYAmt>
        <EOYAmt>188242</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>140038</BOYAmt>
        <EOYAmt>1596763</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>28532</BOYAmt>
        <EOYAmt>37756</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>68581</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>67739</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>1468</BOYAmt>
        <EOYAmt>842</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>4025</BOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>18559</BOYAmt>
        <EOYAmt>18030</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <TotalAssetsGrp>
        <BOYAmt>1434405</BOYAmt>
        <EOYAmt>2460484</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>85330</BOYAmt>
        <EOYAmt>295849</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>85330</BOYAmt>
        <EOYAmt>295849</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1193424</BOYAmt>
        <EOYAmt>2076605</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>155651</BOYAmt>
        <EOYAmt>88030</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>1349075</BOYAmt>
        <EOYAmt>2164635</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>1434405</BOYAmt>
        <EOYAmt>2460484</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>881242</ReconcilationRevenueExpnssAmt>
      <PriorPeriodAdjustmentsAmt>-65682</PriorPeriodAdjustmentsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="990A" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>1376982</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2365343</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1707471</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2594708</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2235980</CurrentTaxYearAmt>
        <TotalAmt>10280484</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>1376982</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2365343</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1707471</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2594708</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2235980</CurrentTaxYearAmt>
        <TotalAmt>10280484</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>969008</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>9311476</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>22088</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>52642</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>5825</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>783</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2037</CurrentTaxYearAmt>
        <TotalAmt>83375</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>10363859</TotalSupportAmt>
      <PublicSupportCY170Pct>0.89850</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.84940</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <PublicSupportCY509Pct>0.00000</PublicSupportCY509Pct>
      <InvestmentIncomeCYPct>0.00000</InvestmentIncomeCYPct>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="990B" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleC documentId="990C" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <VolunteersInd>true</VolunteersInd>
      <PaidStaffOrManagementInd>true</PaidStaffOrManagementInd>
      <MediaAdvertisementsInd>false</MediaAdvertisementsInd>
      <MailingsMembersInd>false</MailingsMembersInd>
      <PublicationsOrBroadcastInd>true</PublicationsOrBroadcastInd>
      <PublicationsOrBroadcastAmt>1875</PublicationsOrBroadcastAmt>
      <GrantsOtherOrganizationsInd>false</GrantsOtherOrganizationsInd>
      <DirectContactLegislatorsInd>true</DirectContactLegislatorsInd>
      <DirectContactLegislatorsAmt>83881</DirectContactLegislatorsAmt>
      <RalliesDemonstrationsInd>false</RalliesDemonstrationsInd>
      <OtherActivitiesInd>true</OtherActivitiesInd>
      <OtherActivitiesAmt>6700</OtherActivitiesAmt>
      <TotalLobbyingExpendituresAmt>92456</TotalLobbyingExpendituresAmt>
      <NotDescribedSection501c3Ind>false</NotDescribedSection501c3Ind>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>II-B 1A AND 1B</FormAndLineReferenceDesc>
        <ExplanationTxt>AN ANNUAL EVENT, ADVOCACY WEEK, IS HELD IN APRIL IN WASHINGTON DC VIRTUAL IN 2020. ORGANIZED BY THE DIRECTOR OF ADVOCACY WITH ASSISTANCE FROM LOBBYING CONSULTANTS THORN RUN, PATIENTS, CAREGIVERS AND SUPPORTERS ARE SCHEDULED FOR MEETINGS WITH LEGISLATORS WHERE THEY TELL OF THEIR EXPERIENCES AND ADVOCATE FOR SUPPORT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>II-B 1E</FormAndLineReferenceDesc>
        <ExplanationTxt>PRESS RELEASE FOR ADVOCACY WEEK</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>II-B 1G</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS INCLUDES DIRECTOR OF ADVOCACY TIME AND LOBBYIST FEES TO SET MEETINGS WITH LEGISLATORS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>II-B 1I</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS IS ADVOCACY WEEK TRAINING</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="990D" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <InclEscrowCustodialAcctLiabInd>false</InclEscrowCustodialAcctLiabInd>
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>18222</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-192</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>18030</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>17222</BeginningYearBalanceAmt>
        <ContributionsAmt>1000</ContributionsAmt>
        <EndYearBalanceAmt>18222</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>16825</BeginningYearBalanceAmt>
        <ContributionsAmt>400</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-3</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>17222</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>15543</BeginningYearBalanceAmt>
        <ContributionsAmt>200</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>1082</InvestmentEarningsOrLossesAmt>
        <EndYearBalanceAmt>16825</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>15543</BeginningYearBalanceAmt>
        <EndYearBalanceAmt>15543</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <PrmnntEndowmentBalanceEOYPct>1.00000</PrmnntEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>true</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>68581</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>67739</DepreciationAmt>
        <BookValueAmt>842</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>842</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>Financial derivatives and other financial products</Desc>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>Closely-held equity interests</Desc>
      </OtherSecuritiesGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>Federal income taxes</Desc>
      </OtherLiabilitiesOrgGrp>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>3890432</TotalRevEtcAuditedFinclStmtAmt>
      <DonatedServicesAndUseFcltsAmt>220884</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>220884</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>3669548</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>3669548</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>3009190</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>220884</DonatedServicesUseFcltsAmt>
      <ExpensesNotReportedAmt>220884</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2788306</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>2788306</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>X 2</FormAndLineReferenceDesc>
        <ExplanationTxt>SOLVE M.E. IS INCORPORATED AS A NONPROFIT VOLUNTARY HEALTH AGENCY UNDER THE LAWS OF THE STATE OF NORTH CAROLINA AND QUALIFIED TO TRANSACT INTRASTATE BUSINESS IN THE STATE OF CALIFORNIA. FURTHER, SOLVE M.E. IS EXEMPT FROM FEDERAL INCOME TAX AS AN ORGANIZATION DESCRIBED IN SECTION 501C3 OF THE INTERNAL REVENUE CODE AND QUALIFIES AS A PUBLIC CHARITY UNDER CODE SECTIONS 509A1 AND 170B1AVI. ACCOUNTING STANDARDS REQUIRE AN ORGANIZATION TO EVALUATE ITS TAX POSITIONS AND PROVIDE FOR A LIABILITY FOR ANY POSITIONS THAT WOULD NOT BE CONSIDERED MORE LIKELY THAN NOT TO BE UPHELD UNDER A TAX AUTHORITY EXAMINATION. MANAGEMENT HAS EVALUATED ITS TAX POSITIONS AND HAS CONCLUDED THAT A PROVISION FOR A TAX LIABILITY IS NOT NECESSARY AT JUNE 30, 2020. GENERALLY, SOLVE M.E.S INFORMATION RETURNS REMAIN OPEN FOR EXAMINATION FOR A PERIOD OF THREE FEDERAL OR FOUR STATE OF CALIFORNIA YEARS FROM THE DATE OF FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>V 4</FormAndLineReferenceDesc>
        <ExplanationTxt>THE PURPOSE OF THE ORGANIZATIONS ENDOWMENT FUND IS TO SECURE THE FUTURE OF SOLVE M.E AND SUPPORT ITS PROGRAMS AND OPERATIONS</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="990F" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe Including Iceland and Greenland</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH ON ME/CFS</PurposeOfGrantTxt>
        <CashGrantAmt>15000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe Including Iceland and Greenland</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH ON ME/CFS</PurposeOfGrantTxt>
        <CashGrantAmt>25000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE</MannerOfCashDisbursementTxt>
      </GrantsToOrgOutsideUSGrp>
      <TotalOtherOrgCnt>2</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>false</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>false</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>false</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>false</ForeignPartnershipInd>
      <BoycottCountriesInd>false</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I Line 2</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS ON RESEARCH PROGRESS AND FINDINGS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part II Line 1</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ACCRUAL ACCOUNTING METHOD IS USED</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="990I" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Autoimmunity Research Inc</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3423 Hill Canyon Avenue</AddressLine1Txt>
          <CityNm>Thousand Oaks</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91360</ZIPCd>
        </USAddress>
        <RecipientEIN>201137851</RecipientEIN>
        <CashGrantAmt>20000</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Johns Hopkins University School of Medicine</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>725 N Wolfe St</AddressLine1Txt>
          <CityNm>Baltimore</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21205</ZIPCd>
        </USAddress>
        <RecipientEIN>526054078</RecipientEIN>
        <CashGrantAmt>14931</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Mass General Hospital - Research</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO Box 414876</AddressLine1Txt>
          <CityNm>Boston</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02410</ZIPCd>
        </USAddress>
        <RecipientEIN>042697983</RecipientEIN>
        <CashGrantAmt>40000</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Stanford University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>455 Broadway</AddressLine1Txt>
          <CityNm>Redwood City</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94063</ZIPCd>
        </USAddress>
        <RecipientEIN>941156365</RecipientEIN>
        <CashGrantAmt>40000</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Tufts University</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>Ballou Hall 4th floor</AddressLine1Txt>
          <CityNm>Medford</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02155</ZIPCd>
        </USAddress>
        <RecipientEIN>042103634</RecipientEIN>
        <CashGrantAmt>20000</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>HudsonAlpha Institute for Biotechnology</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1720 2nd Ave South</AddressLine1Txt>
          <CityNm>Birmingham</CityNm>
          <StateAbbreviationCd>AL</StateAbbreviationCd>
          <ZIPCd>35294</ZIPCd>
        </USAddress>
        <RecipientEIN>272320591</RecipientEIN>
        <CashGrantAmt>32500</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UCLA Foundation</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>10889 Wilshire Blvd 12th Floor</AddressLine1Txt>
          <CityNm>Los Angeles</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90024</ZIPCd>
        </USAddress>
        <RecipientEIN>952250801</RecipientEIN>
        <CashGrantAmt>50000</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>Univ of Massachusetts Medical School</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>55 Lake Avenue N</AddressLine1Txt>
          <CityNm>Worcester</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01655</ZIPCd>
        </USAddress>
        <RecipientEIN>043145945</RecipientEIN>
        <CashGrantAmt>27500</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Nevada Reno</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1664 N Virginia St 204 Ross Hall MS</AddressLine1Txt>
          <CityNm>Reno</CityNm>
          <StateAbbreviationCd>NV</StateAbbreviationCd>
          <ZIPCd>89557</ZIPCd>
        </USAddress>
        <RecipientEIN>880387136</RecipientEIN>
        <CashGrantAmt>20000</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Utah</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>201 S Presidents Cir Rm 406</AddressLine1Txt>
          <CityNm>Salt Lake</CityNm>
          <StateAbbreviationCd>UT</StateAbbreviationCd>
          <ZIPCd>84112</ZIPCd>
        </USAddress>
        <RecipientEIN>876000525</RecipientEIN>
        <CashGrantAmt>22500</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>University of Vermont</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>85 South Prospect Street</AddressLine1Txt>
          <CityNm>Burlington</CityNm>
          <StateAbbreviationCd>VT</StateAbbreviationCd>
          <ZIPCd>05405</ZIPCd>
        </USAddress>
        <RecipientEIN>451556038</RecipientEIN>
        <CashGrantAmt>26786</CashGrantAmt>
        <PurposeOfGrantTxt>TO CONQUER ME/CFS</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>11</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I Line 2</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS ON RESEARCH PROGRESS AND FINDINGS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleM documentId="990M" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>5</ContributionCnt>
        <NoncashContributionsRptF990Amt>45144</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>SALES PRICE</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <AnyPropertyThatMustBeHeldInd>false</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>true</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>false</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Part I Line 9</FormAndLineReferenceDesc>
        <ExplanationTxt>THE NUMBER REPRESENTS THE NUMBER OF CONTRIBUTIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="990O" softwareId="19009610" softwareVersionNum="19.2.1.0">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part XI, Line 8</FormAndLineReferenceDesc>
        <ExplanationTxt>DURING THE YEAR ENDED JUNE 30, 2020, SMCI DETERMINED THAT IT HAD IMPROPERLY RECONCILED AND ACCOUNTED FOR THE BALANCE IN ITS PRIMARY CHECKING ACCOUNT AS OF JUNE 30, 2019. THE CORRECTION OF THIS ERROR DECREASED CASH AND NET ASSETS WITHOUT DONOR RESTRICTION AS OF JUNE 30, 2019 BY 65,682.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4A, Line 1</FormAndLineReferenceDesc>
        <ExplanationTxt>The most important accomplishment of the year was the launch of the testing version of the You ME Registry. It was developed with input from members of the community and experts over the past couple of years. You ME collects health information from people living with ME/CFS and controls. The registry platform includes a web-based user portal that allows for easy data entry, while protecting participant privacy. After a person with ME/ CFS or someone without the disease a control registers on the website, they can complete surveys that capture their health history, quality of life, other diagnoses, treatments and outcomes.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4A, Line 2</FormAndLineReferenceDesc>
        <ExplanationTxt>They can also use a tracking smartphone application app to capture their daily experience with the disease. The You ME registry is the first of its kind to be used specifically for ME/CFS and will provide an unparalleled research platform. This database may identify triggers or causes of the diseases, subgroups of patients and ultimately may be used to develop diagnostics and treatments. In Fall 2019, Solve M.E. announced it would fund seven studies in 2020 through the Ramsay program, welcoming over 30 investigators and collaborators, including a number of early career stage scientists. Over half of these research teams included a Principal Investigator PI leading an ME/CFS study for the first time. A Ramsay Network teleconference was hosted with presentations from National Institutes of Health NIH. The results of studies that received support from the Ramsay Grant Program were published in prestigious scientific journals. Bhupesh Prusty, PhD, Robert Naviaux, MD, PhD and an international team published findings in</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4A, Line 3</FormAndLineReferenceDesc>
        <ExplanationTxt>ImmunoHorizons that Human Herpesvirus 6 HHV-6 could be driving cellular energy production problems in at least some people with ME/CFS. Carmen Scheibenbogen, MD, PHD published a genetic association study that suggests an association between autoimmunity genetic risk variants and people with infectious onset ME/CFS in Frontiers in Immunology. Published ME/CFS Research Two grant applications were submitted through the Congressionally Directed Medical Research Program CDMRP to use the registry data for research and to study the emerging COVID-19 crisis. This funding mechanism was made available for ME/CFS research as a result of our advocacy work.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4A, Line 4</FormAndLineReferenceDesc>
        <ExplanationTxt>Solve ME announced a partnership with the University of California, Los Angeles UCLA Iris Cantor Womens Health Center to issue an ME/CFS specific funding announcement through their Annual Health Pilot Program. They have a demonstrated record obtaining large NIH grans as follow on to the pilot projects. Approximately 27 million return on investment for 1 million invested.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4A, Line 5</FormAndLineReferenceDesc>
        <ExplanationTxt>Solve M.E. Chief Scientific Officer Dr. Sadie Whittaker presented on the YOU M.E. Registry at the 6th Annual Science Conference held by the UK CFS/M.E. Research Collaborative CMRC.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 1</FormAndLineReferenceDesc>
        <ExplanationTxt>As part of our ongoing efforts to increase funding for ME/CFS at the federal level, Solve M.E. added five national coalition and advocacy partnerships designed to accelerate our strategies to appropriate funds for ME/CFS medical research. As part of our expanded advocacy impact, Solve M.E. worked with our ME/CFS constituents to deliver 5,031 online messages to Congress. Together with expanded coalitions and communication programs, Solve M.E. worked to influence congressional appropriations actions and educate regarding paid family leave and telehealth legislation and Coronavirus legislation including dedicated relief for federally funded research.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 2</FormAndLineReferenceDesc>
        <ExplanationTxt>The 4th Annual ME/CFS Advocacy week and Advocacy Day was moved to a virtual platform due to the coronavirus outbreak. 318 registered ME/CFS patient, caregivers, and supporters attended a record 245 meetings with members of U.S. Congress and their staff. In addition to sharing their personal experiences with ME/CFS, participants called on Congress to increase funding for biomedical research programs targeting COVID-19 patients who develop ME/CFS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 3</FormAndLineReferenceDesc>
        <ExplanationTxt>Through Solve MEs new online action toolkit, 111 people took action on Twitter and the custom ME/CFS awareness GIF was viewed 109,846 times. As part of the weeks activities, Solve M.E. hosted the second annual EmPOWER M.E. patient education roundtable. This years there was How to Navigate Disability Insurance with ME/CFS. The webinar roundtable was livestreamed and is now available on the Solve M.E YouTube channel. This years event also featured online office hours afterwards where two EmPOWER M.E panelists answered specific questions regarding disability claims and other issues.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 4</FormAndLineReferenceDesc>
        <ExplanationTxt>Following advocacy educational presentations, community mobilization, and constituent meetings, several legislators took action to support people with ME/CFS, including Senator Ed Markey and Congressman Jamie Raskin</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 5</FormAndLineReferenceDesc>
        <ExplanationTxt>Solve M.E. launched the inaugural cohort of the Community Advisory Council CAC with 14 community members and advocates from across the United States and Canada. The CAC is a volunteer working group that provides guidance and recommendations on numerous Solve M.E. programs. It serves as an inclusive partner platform to facilitate the input, dialogue, and collaborations with representatives of the ME/CFS community.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 6</FormAndLineReferenceDesc>
        <ExplanationTxt>In its first year, members of the CAC worked with Solve M.E. staff on issues related to ME/CFS advocacy, education, and engagement and were available to review applications for funding through the EmPOWER M.E. micro grant program.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Section 4B, Line 7</FormAndLineReferenceDesc>
        <ExplanationTxt>Expansion of Solve M.E.s advocacy education program continued by creating and staging 6 in-person and online medical and community education presentations designed to train the ME/CFS community on contacting representatives and effective modes of communicating key ME/CFS issues. Solve M.E. also created a new page on its website, COVID-19 and the ME/CFS Community, to provide updates. information and resources during the pandemic.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FINANCE COMMITTEE IS RESPONSIBLE FOR REVIEWING THE ORGANIZATIONS FORM 990 AND PROVIDING COMMENTS PRIOR TO IT BEING SUBMITTED TO THE INTERNAL REVENUE SERVICE. ALL MEMBERS OF THE BOARD OF DIRECTORS RECEIVE A COPY OF THE REVIEWED FORM 990 PRIOR TO ITS SUBMISSION TO THE IRS, BUT ARE NOT REQUIRED TO PROVIDE COMMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part V, Section C, Line 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATIONS FORM 990 AND ANNUAL REPORT ARE AVAILABLE ON ITS WEBSITE WWW.SOLVECFS.ORG. THE 990 IS ALSO AVAILABLE ON GUIDESTAR. UPON REQUEST THE ORGANIZATION WILL MAKE AVAILABLE COPIES OF ITS AUDITED FINANCIAL STATEMENTS, FORM 1023, GOVERNING BY-LAWS AND CONFLICTS OF INTEREST POLICY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>EMPLOYEES OF THE ORGANIZATION UNDERGO PERIODIC PERFORMANCE AND COMPENSATION REVIEWS. COMPENSATION LEVEL IS DETERMINED UPON PERFORMANCE, MARKET AND THE FINANCIAL POSITION OF THE ORGANIZATION. THE PRESIDENT PERFORMS ALL REVIEWS EXCEPT FOR THE POSITION OF PRESIDENT WHICHIS DONE BY MEMBERS OF THE PROFESSIONAL STAFF RECRUITING AND COMPENSATION COMMITTEE. THISCOMMITTEE IS COMPRISED OF THE EXECUTIVE COMMITTEE OF THE BOARD. TO ENSURE SALARY COMPENSATION IS COMPARABLE TO SIMILAR ORGANIZATIONS, THE COMMITTEE CONSULTS WITH PUBLISHED SALARY SURVEYS,.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 15B</FormAndLineReferenceDesc>
        <ExplanationTxt>THIS IS MARKED NO SINCE THERE WERE NO OTHER OFFICERS IN THE ORGANIZATION TO WHICH THIS APPLIES</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part VI, Section B, Line 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>DIRECTORS ARE REQUIRED TO SIGN ANNUAL CONFLICTS OF INTEREST FORMS, NOTIFY THE ORGANIZATION OF ANY CONFLICTS OF INTEREST AND RECUSE THEMSELVES FROM DISCUSSING OR VOTING ON ANY MATTERS WHICH ARE A CONFLICT FOR THEM.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>